J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M700330-JLR200 on August 24, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700330-JLR200v1
48/12/2664    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, I.
Right arrow Articles by Gonzalez, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, I.
Right arrow Articles by Gonzalez, F. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 48, 2664-2672, December 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine

Insook Kim*, Sung-Hoon Ahn*, Takeshi Inagaki{dagger}, Mihwa Choi{dagger}, Shinji Ito*, Grace L. Guo1,*, Steven A. Kliewer{dagger} and Frank J. Gonzalez2,*

* Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
{dagger} University of Texas Southwestern Medical Center, Dallas, TX 75390

Published, JLR Papers in Press, August 24, 2007.

1 Present address of G. L. Guo: University of Kansas Medical Center, Kansas City, KS 66160.

2 To whom correspondence should be addressed. e-mail: fjgonz{at}helix.nih.gov

Bile acid concentrations are controlled by a feedback regulatory pathway whereby activation of the farnesoid X receptor (FXR) represses transcription of both the CYP7A1 gene, encoding the rate-limiting enzyme in the classic bile acid synthesis pathway, and the CYP8B1 gene, required for synthesis of cholic acid. The tissue-specific roles of FXR were examined using liver- and intestine-specific FXR-null models. FXR deficiency in either liver (Fxr{Delta}L) or intestine (Fxr{Delta}IE) increased bile acid pool size. Treatment with the FXR-selective agonist GW4064 significantly repressed CYP7A1 in Fxr{Delta}L mice but not Fxr{Delta}IE mice, demonstrating that activation of FXR in intestine but not liver is required for short-term repression of CYP7A1 in liver. This intestinal-specific effect of FXR is likely mediated through induction of the hormone FGF15, which suppresses CYP7A1. In comparison to CYP7A1, FXR-mediated repression of CYP8B1 was more dependent on the presence of FXR in liver and less dependent on its presence in intestine. Consistent with these findings, recombinant FGF15 repressed CYP7A1 mRNA levels without affecting CYP8B1 expression. These data provide evidence that FXR-mediated repression of bile acid synthesis requires the complementary actions of FXR in both liver and intestine and reveal mechanistic differences in feedback repression of CYP7A1 and CYP8B1.

Supplementary key words FXR • FGF15 • CYP7A1 • CYP8B1 • liver-specific FXR null mice • intestine-specific FXR null mice

Abbreviations: BW, body weight; CA, cholic acid; DCA, deoxycholic acid; FXR, farnesoid X receptor; LC-MS/MS, liquid chromatography tandem mass spectrometry; MCA, murocholic acid; RT-qPCR, real-time quantitative PCR; TCA, taurocholic acid; TDCA, taurodeoxycholic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
Y.-K. Lee, D. R. Schmidt, C. L. Cummins, M. Choi, L. Peng, Y. Zhang, B. Goodwin, R. E. Hammer, D. J. Mangelsdorf, and S. A. Kliewer
Liver Receptor Homolog-1 Regulates Bile Acid Homeostasis but Is Not Essential for Feedback Regulation of Bile Acid Synthesis
Mol. Endocrinol., June 1, 2008; 22(6): 1345 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. Davis and A. D. Attie
Deletion of the ileal basolateral bile acid transporter identifies the cellular sentinels that regulate the bile acid pool
PNAS, April 1, 2008; 105(13): 4965 - 4966.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Rao, J. Haywood, A. L. Craddock, M. G. Belinsky, G. D. Kruh, and P. A. Dawson
The organic solute transporter {alpha}-{beta}, Ost{alpha}-Ost{beta}, is essential for intestinal bile acid transport and homeostasis
PNAS, March 11, 2008; 105(10): 3891 - 3896.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. A. Davis
Resolving the mechanism of bile acid negative-feedback regulation, a Journal of Lipid Research tradition
J. Lipid Res., January 1, 2008; 49(1): 2 - 3.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.